Zephyr Valve Registry (ZEVR)

Running, not enrolling

Conditions studied: Emphysema

In brief

The purpose of this Post-Approval Registry is to gather ongoing safety and effectiveness assessment of the Zephyr Valve treatment in a real-world setting.

Key facts

Study ID

NCT04186546

Run by

Pulmonx Corporation

People needed

150

Starts

2019-11-25

Expected to finish

2026-12-31

Last updated by the study team

2025-04-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with severe emphysema considered appropriate for the procedure by the physician.
• Subjects who signed an Informed Consent Form to allow data collection.

You may not qualify if…

• Subjects determined to have collateral ventilation between the target(s) and ipsilateral lobe(s).

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• University of Chicago — Chicago, Illinois, United States
• Northwestern Medicine — Winfield, Illinois, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• The Lung Center — DuBois, Pennsylvania, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Temple University Hospital — Philadelphia, Pennsylvania, United States
• University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States
• Houston Methodist — Houston, Texas, United States
• Inova Health — Fairfax, Virginia, United States
• Froedtert Memorial-Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.